Compare TransMedics Group Inc (TMDX) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Zillow Group Inc Class C — how do they compare? TransMedics Group Inc trades at $74.23 (market cap $2.54B), while Zillow Group Inc Class C trades at $31.76 (market cap $7.54B). The key difference: Zillow Group Inc Class C is far larger — about 3× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| TMDX | Z | |
|---|---|---|
Market Cap | $2.54B | $7.54B |
Sector | Technology | Media |
52-Week High | $150.42 | $90.35 |
52-Week Low | $61.99 | $29.41 |
Enterprise Value | $2.94B | $7.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics (TMDX) trades at $73.47, down 0.69% with neutral technical signals. The stock shows strong profitability with 27% net margins and 45% ROE, though Q1 2026 earnings missed expectations. Recent strategic investment in European aviation logistics aims to expand the Organ Care System platform. Analyst consensus remains bullish with a $108.71 price target representing 48% upside potential.
Long-term growth prospects appear solid given TMDX's expanding transplant ecosystem, but near-term margin pressure from expansion investments and execution risks warrant caution. The company maintains competitive advantages in organ transplant logistics, though increased spending and competitive threats from alternatives like Strata Critical Medical present headwinds for shareholder returns.
Zillow Group (Z) trades at $33.03, down 2.58% today, amid ongoing class action lawsuits alleging securities fraud between February 2025 and May 2026. The stock shows mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, revenue grew to $2.58B in 2025 with a net income of $23M, yet high P/E of 135.72 reflects premium valuation. Analyst consensus is divided with 46% Buy, 50% Hold, and a $57.67 price target implying significant upside from current levels.
The outlook is clouded by legal risks and volatile cash flows, but improving profitability and analyst targets suggest long-term potential if the company navigates litigation successfully. Key risks include lawsuit outcomes and competitive pressures in real estate tech, while institutional sentiment remains cautiously optimistic given the growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
